Zeige Ergebnisse 211 - 218 von 218
1997
Hothorn LA, Martin U. Application of adaptive interim analysis in pharmacology. Therapeutic Innovation & Regulatory Science. 1997 Dez 30;31(2):615-619. doi: 10.1177/009286159703100229, https://doi.org/10.15488/2981
Hothorn LA. Guest editor's note: Biostatistics in preclinical studies. Therapeutic Innovation & Regulatory Science. 1997 Dez 30;31(2):321-322. doi: 10.1177/009286159703100201, https://doi.org/10.15488/3010
Hothorn LA. Modifications of the closure principle for analyzing toxicological studies. Therapeutic Innovation & Regulatory Science. 1997 Dez 30;31(2):403-412. doi: 10.1177/009286159703100211, https://doi.org/10.15488/3022
Hothorn LA, Lin KK, Hamada C, Rebel W. Recommendations for biostatistics of repeated toxicity studies. Therapeutic Innovation & Regulatory Science. 1997 Dez 20;31(2):327-334. doi: 10.1177/009286159703100203, https://doi.org/10.1177/009286159703100203
Kropf S, Hothorn LA, Läuter J. Multivariate many-to-one procedures with applications to preclinical trials. Therapeutic Innovation & Regulatory Science. 1997 Dez 30;31(2):433-447. doi: 10.1177/009286159703100214, https://doi.org/10.15488/3023
Neuhäuser M, Hothorn LA. The control of the consumer risk in the Ames assay. Drug Information Journal. 1997 Dez 30;31(2):363-367. doi: 10.1177/009286159703100207, https://doi.org/10.15488/3052
Neuhäuser M, Hothorn LA. Trend tests for dichotomous endpoints with application to carcinogenicity studies. Therapeutic Innovation & Regulatory Science. 1997 Dez 30;31(2):463-469. doi: 10.1177/009286159703100217, https://doi.org/10.15488/3057
1996
Hauschke D, Steinijans VW, Hothorn LA. A note on Welch's approximate t-solution to bioequivalence assessment. BIOMETRIKA. 1996 Mär 1;83(1):236-237. doi: 10.1093/biomet/83.1.236
